LuciOlap 150mg is a targeted cancer treatment used for managing ovarian breast and prostate cancers associated with BRCA mutations. It works by interfering with cancer cell repair mechanisms leading to cell death. This medicine is widely used in oncology care across the United Kingdom, United States, Australia, Singapore and Philippines. LuciOlap provides a personalized treatment approach and is often prescribed when cancer is resistant to standard therapies improving patient outcomes and disease control.
Active Ingredient
Olaparib is a PARP inhibitor that blocks poly ADP ribose polymerase enzymes involved in DNA repair. It belongs to a class of targeted therapies designed to exploit genetic weaknesses in cancer cells.
Uses of LuciOlap 150mg
• Treatment of ovarian cancer
• Management of breast cancer
• Relief from cancer progression
• Support for BRCA mutated cancers
How LuciOlap 150mg Works
Olaparib inhibits PARP enzymes that help repair damaged DNA in cancer cells. When this repair process is blocked cancer cells accumulate damage and eventually die. This targeted action makes it effective for cancers with defective DNA repair pathways.
How to Use LuciOlap 150mg
1. Take tablets as prescribed by your doctor
2. Swallow whole with water
3. Maintain consistent dosing schedule
Possible Side Effects
• Nausea
• Fatigue
• Anemia
• Loss of appetite
Precautions
• Monitor blood counts regularly
• Avoid during pregnancy
• Inform doctor about kidney issues
Safety Information
LuciOlap should be used under strict medical supervision. Follow prescribed dosage and attend regular checkups to monitor effectiveness and safety.
Storage
• Store at room temperature
• Protect from moisture
• Keep out of reach of children
